Menu
GeneBe

8-70138295-C-G

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2

The NM_006540.4(NCOA2):ā€‹c.3066G>Cā€‹(p.Gln1022His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000924 in 1,613,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00045 ( 0 hom., cov: 33)
Exomes š‘“: 0.000055 ( 0 hom. )

Consequence

NCOA2
NM_006540.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.759
Variant links:
Genes affected
NCOA2 (HGNC:7669): (nuclear receptor coactivator 2) The protein encoded by this gene functions as a transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid, and vitamin D receptors. The encoded protein acts as an intermediary factor for the ligand-dependent activity of these nuclear receptors, which regulate their target genes upon binding of cognate response elements. This gene has been found to be involved in translocations that result in fusions with other genes in various cancers, including the lysine acetyltransferase 6A (KAT6A) gene in acute myeloid leukemia, the ETS variant 6 (ETV6) gene in acute lymphoblastic leukemia, and the hes related family bHLH transcription factor with YRPW motif 1 (HEY1) gene in mesenchymal chondrosarcoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PP2
Missense variant where missense usually causes diseases, NCOA2
BP4
Computational evidence support a benign effect (MetaRNN=0.017793268).
BS2
High AC in GnomAd4 at 69 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NCOA2NM_006540.4 linkuse as main transcriptc.3066G>C p.Gln1022His missense_variant 15/23 ENST00000452400.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NCOA2ENST00000452400.7 linkuse as main transcriptc.3066G>C p.Gln1022His missense_variant 15/231 NM_006540.4 P1
NCOA2ENST00000518363.2 linkuse as main transcriptc.444G>C p.Gln148His missense_variant 3/112
NCOA2ENST00000522054.1 linkuse as main transcriptn.97G>C non_coding_transcript_exon_variant 2/23
NCOA2ENST00000518287.6 linkuse as main transcriptc.*23G>C 3_prime_UTR_variant, NMD_transcript_variant 14/215

Frequencies

GnomAD3 genomes
AF:
0.000460
AC:
70
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00167
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000137
AC:
34
AN:
247568
Hom.:
0
AF XY:
0.000156
AC XY:
21
AN XY:
134320
show subpopulations
Gnomad AFR exome
AF:
0.00202
Gnomad AMR exome
AF:
0.0000875
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000548
AC:
80
AN:
1460956
Hom.:
0
Cov.:
30
AF XY:
0.0000537
AC XY:
39
AN XY:
726716
show subpopulations
Gnomad4 AFR exome
AF:
0.00200
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.00e-7
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.000453
AC:
69
AN:
152294
Hom.:
0
Cov.:
33
AF XY:
0.000470
AC XY:
35
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00164
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000427
Hom.:
0
Bravo
AF:
0.000529
ESP6500AA
AF:
0.00135
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000174
AC:
21

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 08, 2022The c.3066G>C (p.Q1022H) alteration is located in exon 15 (coding exon 13) of the NCOA2 gene. This alteration results from a G to C substitution at nucleotide position 3066, causing the glutamine (Q) at amino acid position 1022 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.069
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.018
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.2
L
MutationTaster
Benign
0.99
D;D
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.21
Sift
Benign
0.23
T
Sift4G
Benign
0.16
T
Polyphen
0.15
B
Vest4
0.35
MutPred
0.097
Gain of glycosylation at P1021 (P = 0.2512);
MVP
0.71
MPC
0.13
ClinPred
0.036
T
GERP RS
4.1
Varity_R
0.060
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371139839; hg19: chr8-71050530; API